Table 1.

Clinical characters of patients with or without EMI subject to circRNA expression profiles

Case	Age	FAB	Karyotype	Gene mutation	Group
1	68	M5a	Normal	RUNX1; ASXL1; TET2; IDH2	EMI
2	49	M5a	Normal	IDH2; STAG2; NRAS	EMI
3	35	M2b	46,XX,der(1)ins(21;1)(q22;q21,q42)der(8)t(8;21)(q22;q22),der(21)t(8;21)ins(21;1)	KIT	EMI
4	64	M4	Normal	N/A	EMI
5	42	M5b	Normal	NMP1; DNMT3A; PTPN11; SMC3	Non-EMI
6	23	M2a	Normal	None	Non-EMI
7	48	M1	Normal	None	Non-EMI
8	31	M2a	Normal	None	Non-EMI
9	32	N/A	N/A	N/A	Healthy volunteers
10	28	N/A	N/A	N/A	Healthy volunteers
11	37	N/A	N/A	N/A	Healthy volunteers
12	41	N/A	N/A	N/A	Healthy volunteers

FAB French–American–British classification system classifications, N/A not available, EMI extramedullary infiltration